Call for Proposals: Pfizer CTI
We are pleased to announce a call for proposals for Pfizer’s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics.
Deadline: October 21, 2019
Areas of Interest and Targets/Pathways of Focus:
- Opportunities related to tissue-resident immunity with application in the fields of inflammation, fibrosis, autoimmunity and oncology
- Opportunities related to DNA damage response and replicative stress with application in the fields of oncology, immunology, and rare diseases
- Novel strategies targeting the cause of repeat expansion diseases
Submission Process: Submission entails a non-confidential 2-3 page overview of the target, mechanism, evidence for disease linkage, and the proposed therapeutic drug. At a high level, the pre-proposal should suggest how the therapeutic hypothesis could be tested in the clinic. Please submit non-confidential pre-proposals to Technology Development by October 21st. For further information about submitting a pre-proposal, please contact Nevena Dimova at ndimova@bu.edu
Request for Proposals: Download | Pre-proposal Template: Download